Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript.

De Cecco L, Gariboldi M, Reid JF, Lagonigro MS, Tamborini E, Albertini V, Staurengo S, Pilotti S, Pierotti MA.

Histopathology. 2005 Mar;46(3):334-41.

PMID:
15720420
2.

Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.

Schwarzbach MH, Koesters R, Germann A, Mechtersheimer G, Geisbill J, Winkler S, Niedergethmann M, Ridder R, Buechler MW, von Knebel Doeberitz M, Willeke F.

Oncogene. 2004 Sep 2;23(40):6798-805.

PMID:
15286712
4.

Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.

Kuroda M, Ishida T, Horiuchi H, Kida N, Uozaki H, Takeuchi H, Tsuji K, Imamura T, Mori S, Machinami R, et al.

Am J Pathol. 1995 Nov;147(5):1221-7.

5.

Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas.

Olofsson A, Willén H, Göransson M, Engström K, Meis-Kindblom JM, Stenman G, Kindblom LG, Aman P.

Int J Oncol. 2004 Nov;25(5):1349-55.

PMID:
15492825
6.

[Molecular diagnosis of liposarcomas: identification of the chimeric genes FUS/CHOP and EWS/CHOP].

Kekeeva TV, Riazantseva AA, Anreeva IuIu, Zavalishina LE, Babenko OV, Zaletaev DV, Petrov AN, Frank GA.

Arkh Patol. 2009 Sep-Oct;71(5):32-5. Russian.

PMID:
19938700
7.

Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.

Hisaoka M, Tsuji S, Morimitsu Y, Hashimoto H, Shimajiri S, Komiya S, Ushijima M.

Diagn Mol Pathol. 1998 Apr;7(2):96-101.

PMID:
9785008
8.

Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.

Rivero ER, Mesquita RA, de Sousa SC, Nunes FD.

Ann Diagn Pathol. 2006 Feb;10(1):36-8.

PMID:
16414544
9.

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M.

Clin Cancer Res. 2001 Dec;7(12):3977-87.

10.

Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications.

Willeke F, Ridder R, Mechtersheimer G, Schwarzbach M, Duwe A, Weitz J, Lehnert T, Herfarth C, von Knebel Doeberitz M.

Clin Cancer Res. 1998 Jul;4(7):1779-84.

11.

FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.

Rodriguez R, Rubio R, Gutierrez-Aranda I, Melen GJ, Elosua C, García-Castro J, Menendez P.

Stem Cells. 2011 Feb;29(2):179-92. doi: 10.1002/stem.571.

12.

Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.

Antonescu CR, Elahi A, Healey JH, Brennan MF, Lui MY, Lewis J, Jhanwar SC, Woodruff JM, Ladanyi M.

Clin Cancer Res. 2000 Jul;6(7):2788-93.

13.

FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.

Yang X, Nagasaki K, Egawa S, Maruyama K, Futami H, Tsukada T, Yokoyama R, Beppu Y, Fukuma H, Shimoda T, et al.

Jpn J Clin Oncol. 1995 Dec;25(6):234-9.

PMID:
8523819
14.

Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.

Pérez-Losada J, Sánchez-Martín M, Rodríguez-García MA, Pérez-Mancera PA, Pintado B, Flores T, Battaner E, Sánchez-Garćia I.

Oncogene. 2000 Dec 7;19(52):6015-22.

15.

[Detection of FUS-CHOP fusion gene in paraffin-embedded tissues and its clinicopathologic significance for myxoid/round cell liposarcomas].

Xiang H, Wang J, Sun MH, Lu L, Shui RH, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2005 Jan;34(1):28-32. Chinese.

PMID:
15796878
16.

Myxoid liposarcoma confirmed by TLS/FUS-CHOP fusion transcripts.

Huang YL, Hong HS, Kuo TT, Chung CJ.

Dermatol Surg. 2003 Sep;29(9):980-1.

PMID:
12930346
17.

Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.

Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Ron D, Sasaki MS, Toguchida J.

Oncogene. 1999 Jan 21;18(3):721-9.

18.

Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice.

Pérez-Mancera PA, Pérez-Losada J, Sánchez-Martín M, Rodríguez-García MA, Flores T, Battaner E, Gutiérrez-Adán A, Pintado B, Sánchez-García I.

Oncogene. 2002 Mar 7;21(11):1679-84.

19.

A novel FUS/CHOP chimera in myxoid liposarcoma.

Panagopoulos I, Mertens F, Isaksson M, Mandahl N.

Biochem Biophys Res Commun. 2000 Dec 29;279(3):838-45.

PMID:
11162437
20.

Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.

Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL.

Am J Surg Pathol. 2009 May;33(5):645-58. doi: 10.1097/PAS.0b013e3181963c9c.

PMID:
19194281

Supplemental Content

Support Center